Flos Lonicera combined with metformin ameliorates Hepatosteatosis and glucose intolerance in association with gut microbiota modulation
Genetic predisposition in peptide signaling pathways can also provide context for how individual patients metabolize and respond to GLP-1 medications, supporting more tailored clinical decisions
10.3389/fnmol.2020.00138 29 HetzC.ZhangK.KaufmanR
The GLP-1 receptor agonist liraglutide was able to reduce Bax expression in pancreatic cells from T2DM rats, and Bcl-2 expression was increased, islet tissue structure was improved, insulin-positive expression was increased, and -cell apoptosis was reduced (Liu et al., 2021)
Ingredients : Aqua, Glycerin, Propylene Glycol, White Oil, Sorbitol, Isopropyl Myristate, Castor Oil, Hyaluronic Acid, A-arbutin, Xanthan Gum, Allantoin, TriethanolAmine L-Glutathione & Preservatives.